Optimizing heart failure treatment with STAR
Part of Heart & circulation clinical trials.
This study tests a new way to fine-tune heart failure treatment using a tool called STAR. It is for people with stable heart failure who are already on standard medications and feel short of breath or tired with daily activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure (any type) with symptoms that put you in NYHA class II or III.
- You are 18 years or older.
- Your doctor expects you to live more than 6 months.
- You are already on the best standard medications for heart failure (according to ESC guidelines).
- You are not living in a nursing home or rehabilitation center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This study is looking at people with any type of heart failure, whether it's stable and managed at home or newly diagnosed in the hospital. The goal is to learn more about how to improve care, no matter what your ejection fraction level is.
This trial uses a national heart failure registry to see if a new way of monitoring treatment can help optimize therapy for people with heart failure and reduced ejection fraction (a weak heart pump). It may lead to better medication adjustments over time.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This study is testing better ways to understand and manage heart failure where the heart pumps normally but still doesn't work as well as it should. It looks at people with symptoms like shortness of breath and fatigue, using blood tests and heart imaging to check eligibility.
This trial tests if using a combination of biomarkers can help personalize treatment for people with a specific type of heart failure called HFpEF (or heart failure with preserved ejection fraction). It aims to find better treatments based on your individual test results.
Hear when a new Heart Failure NYHA Class II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.